Recent Finacing
Recent Raise
Ascentage Pharma is a clinical-stage biopharmaceutical developing small-molecule apoptosis-targeted therapies, advancing Bcl-2/Bcl-xL, IAP, MDM2–p53 and next-gen kinase inhibitor programs across US, China.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Ascentage Pharma.